Anti-ZC3HAV1 monoclonal antibody

Pre-made anti-ZC3HAV1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ZC3HAV1/ZC3HAV1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2295-Ab-1/ GM-Tg-hg-IP2295-Ab-2Anti-Human ZC3HAV1 monoclonal antibodyHuman
GM-Tg-rg-IP2295-Ab-1/ GM-Tg-rg-IP2295-Ab-2Anti-Rat ZC3HAV1 monoclonal antibodyRat
GM-Tg-mg-IP2295-Ab-1/ GM-Tg-mg-IP2295-Ab-2Anti-Mouse ZC3HAV1 monoclonal antibodyMouse
GM-Tg-cynog-IP2295-Ab-1/ GM-Tg-cynog-IP2295-Ab-2Anti-Cynomolgus/ Rhesus macaque ZC3HAV1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2295-Ab-1/ GM-Tg-felg-IP2295-Ab-2Anti-Feline ZC3HAV1 monoclonal antibodyFeline
GM-Tg-cang-IP2295-Ab-1/ GM-Tg-cang-IP2295-Ab-2Anti-Canine ZC3HAV1 monoclonal antibodyCanine
GM-Tg-bovg-IP2295-Ab-1/ GM-Tg-bovg-IP2295-Ab-2Anti-Bovine ZC3HAV1 monoclonal antibodyBovine
GM-Tg-equg-IP2295-Ab-1/ GM-Tg-equg-IP2295-Ab-2Anti-Equine ZC3HAV1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2295-Ab-1/ GM-Tg-hg-IP2295-Ab-2; GM-Tg-rg-IP2295-Ab-1/ GM-Tg-rg-IP2295-Ab-2;
GM-Tg-mg-IP2295-Ab-1/ GM-Tg-mg-IP2295-Ab-2; GM-Tg-cynog-IP2295-Ab-1/ GM-Tg-cynog-IP2295-Ab-2;
GM-Tg-felg-IP2295-Ab-1/ GM-Tg-felg-IP2295-Ab-2; GM-Tg-cang-IP2295-Ab-1/ GM-Tg-cang-IP2295-Ab-2;
GM-Tg-bovg-IP2295-Ab-1/ GM-Tg-bovg-IP2295-Ab-2; GM-Tg-equg-IP2295-Ab-1/ GM-Tg-equg-IP2295-Ab-2
Products NameAnti-ZC3HAV1 monoclonal antibody
Formatmab
Target NameZC3HAV1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ZC3HAV1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2295-Ag-1Recombinant multi-species ZCCHV/ ZC3HAV1/ ARTD13 protein


    Target information

    Target IDGM-IP2295
    Target NameZC3HAV1
    Gene ID56829,78781,252832,106997687,100856206,101101454,614589,100064774
    Gene Symbol and Synonyms1200014N16Rik,2900058M19Rik,9130009D18Rik,9830115L13Rik,ARTD13,D6Bwg1452e,FLB6421,PARP13,ZAP,ZC3H2,ZC3HAV1,ZC3HDC2
    Uniprot AccessionQ7Z2W4,Q8K3Y6
    Uniprot Entry NameZCCHV_HUMAN,ZCCHV_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000105939
    Target ClassificationN/A

    The target: ZC3HAV1, gene name: ZC3HAV1, also named as ARTD13, FLB6421, PARP13, ZAP, ZC3H2, ZC3HDC2. This gene encodes a CCCH-type zinc finger protein. This antiviral protein inhibits viral replication by recruiting cellular RNA degradation machineries to degrade viral mRNAs. The encoded protein plays an important role in the innate immune response against multiple DNA and RNA viruses, including Ebola virus, HIV and SARS-CoV-2 (which causes COVID-19). [provided by RefSeq, Sep 2021].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.